We expect to include the updated RANO 2.0 results in our planned upcoming New Drug Application to Australian regulators.” “RANO 2.0 is a recently established response assessment criteria for gliomas ...
We expect to include the updated RANO 2.0 results in our planned upcoming New Drug Application to Australian regulators." "RANO 2.0 is a recently established response assessment criteria for gliomas ...
Calidi's novel stem cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade ...